| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $0.06 (Beat by $0.04845) |
| EPS GAAP Actual | $0.06 (Beat by $0.04845) |
| Revenue Actual | $0.020325B |
| Revenue Surprise | Beat by $20.325M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $0.0213B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0.36 | 15.39 | 0.36 | 0.36 | 1 |
| Dec 2025 | 0.29 | 19.1 | 0.29 | 0.29 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0 | -0.02 | 0.020325B | 13.27% | 1.28M |
| FQ2 2025 (Jun 2025) | -0.033 | -0.063 | 0.017309B | -7.45% | -0.47M |
| FQ1 2025 (Mar 2025) | -0.086 | -0.146 | 0.017338B | -14.03% | -1.94M |
| FQ4 2024 (Dec 2024) | 0.11 | 0.06 | 0.017298B | -4.34% | 0.04M |
| FQ3 2024 (Sep 2024) | 0.05 | 0.02 | 0.017627B | 13.11% | 0.79M |
| FQ2 2024 (Jun 2024) | 0.0015 | -1.34109 | 0.018598B | 30.6% | -7.22M |
| FQ1 2024 (Mar 2024) | 0.08 | -1.49645 | 0.01977B | -35.77% | -2.82M |
| FQ4 2023 (Dec 2023) | 0.0812 | 0.0812 | 0.018049B | -63.93% | 18.05M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
0.0213B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.157 | -- | 0.157 | 0.157 | 1 |
| FQ3 2026 (Sep 2026) | 0 | -- | 0 | 0 | 0 |
| FQ2 2026 (Jun 2026) | 0 | INF | 0 | 0 | 0 |
| FQ1 2026 (Mar 2026) | 0 | INF | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ3 2026 (Sep 2026) | 0.02B | -0.12 | 0.02B | 0.02B | 1 |
| FQ2 2026 (Jun 2026) | 0.02B | 19.87 | 0.02B | 0.02B | 1 |
| FQ1 2026 (Mar 2026) | 0.02B | 18.6 | 0.02B | 0.02B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.02 | 0 | -0.02 | -INF% |
| FQ2 2025 (Jun 2025) | 0.03 | -0.033 | -0.063 | 190.91% |
| FQ1 2025 (Mar 2025) | 0.06 | -0.086 | -0.146 | 169.77% |
| FQ4 2024 (Dec 2024) | 0.05 | 0.11 | 0.06 | 54.55% |
| FQ3 2024 (Sep 2024) | 0.03 | 0.05 | 0.02 | 40% |
| FQ2 2024 (Jun 2024) | 1.34259 | 0.0015 | -1.34109 | -89406% |
| FQ1 2024 (Mar 2024) | 1.57645 | 0.08 | -1.49645 | -1870.56% |
| FQ4 2023 (Dec 2023) | 0.0812 | 0.0812 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.02B | $0.02B | $1.28M | 6.28% |
| FQ2 2025 (Jun 2025) | $0.02B | $0.02B | $-0.47M | -2.72% |
| FQ1 2025 (Mar 2025) | $0.02B | $0.02B | $-1.94M | -11.18% |
| FQ4 2024 (Dec 2024) | $0.02B | $0.02B | $0.04M | 0.24% |
| FQ3 2024 (Sep 2024) | $0.02B | $0.02B | $0.79M | 4.5% |
| FQ2 2024 (Jun 2024) | $0.03B | $0.02B | $-7.22M | -38.8% |
| FQ1 2024 (Mar 2024) | $0.02B | $0.02B | $-2.82M | -14.25% |
| FQ4 2023 (Dec 2023) | $0B | $0.02B | $18.05M | 100% |